Joseph Monahan has sold ACRS and made no open-market buys since Jun 2021
Chief Scientific Officer at Aclaris Therapeutics, Inc.
SEC CIK 0001861790 · Filings on SEC.gov ↗
$0Bought
$2.1MSold
NoneLast buy
Every filing
10 filings since Jun 2021, newest first
ACRSSell
Aclaris Therapeutics, Inc.
Chief Scientific Officer
$30K−4.0%Oct 25
ACRSSell
Aclaris Therapeutics, Inc.
Chief Scientific Officer
$44K−4.0%Aug 22
ACRSSell
Aclaris Therapeutics, Inc.
Chief Scientific Officer
$62K−4.0%Jun 22
ACRSSell
Aclaris Therapeutics, Inc.
Chief Scientific Officer
$386K−17.0%Mar 3
ACRSSell
Aclaris Therapeutics, Inc.
Chief Scientific Officer
$65K−5.0%Feb 17
ACRSSell
Aclaris Therapeutics, Inc.
Chief Scientific Officer
$79K−5.0%Dec 16
ACRSSell
Aclaris Therapeutics, Inc.
Chief Scientific Officer
$80K−5.0%Oct 19
ACRSSell
Aclaris Therapeutics, Inc.
Chief Scientific Officer
$488K−22.0%Apr 20
ACRSSell
Aclaris Therapeutics, Inc.
Chief Scientific Officer
$427K−17.0%Mar 14
ACRSSell
Aclaris Therapeutics, Inc.
Chief Scientific Officer
$471K−20.0%Jun 2
Filings come from SEC EDGAR. Not investment advice.